Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.
Berends CL, Pagan L, van Esdonk MJ, Klarenbeek NB, Bergmann KR, Moerland M, van der Wel V, de Visser SJ, Büller H, de Loos F, de Vries WS, Waals H, de Leede LGJ, Burggraaf J, Kamerling IMC. Berends CL, et al. Among authors: burggraaf j. Pharmacol Res Perspect. 2021 Apr;9(2):e00739. doi: 10.1002/prp2.739. Pharmacol Res Perspect. 2021. PMID: 33764642 Free PMC article. Clinical Trial.
Dose-related effects of motilin on proximal gastrointestinal motility.
Kamerling IM, Van Haarst AD, Burggraaf J, Schoemaker HC, Biemond I, Jones R, Cohen AF, Masclee AA. Kamerling IM, et al. Among authors: burggraaf j. Aliment Pharmacol Ther. 2002 Jan;16(1):129-35. doi: 10.1046/j.1365-2036.2002.01142.x. Aliment Pharmacol Ther. 2002. PMID: 11856087 Free article. Clinical Trial.
Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers.
Kamerling IM, Van Haarst AD, Burggraaf J, Schoemaker RC, Biemond I, Heinzerling H, Jones R, Cohen AF, Masclee AA. Kamerling IM, et al. Among authors: burggraaf j. Am J Physiol Gastrointest Liver Physiol. 2003 May;284(5):G776-81. doi: 10.1152/ajpgi.00456.2002. Epub 2003 Jan 2. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12519743 Free article. Clinical Trial.
The effect of motilin on the rectum in healthy volunteers.
Kamerling IM, Burggraaf J, van Haarst AD, Oppenhuizen-Duinker MF, Schoemaker HC, Biemond I, Jones R, Heinzerling H, Cohen AF, Masclee AA. Kamerling IM, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2003 Jun;55(6):538-43. doi: 10.1046/j.1365-2125.2003.01812.x. Br J Clin Pharmacol. 2003. PMID: 12814447 Free PMC article. Clinical Trial.
Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function.
Kamerling IM, van Haarst AD, Burggraaf J, Schoemaker RC, de Kam ML, Heinzerling H, Cohen AF, Masclee AA. Kamerling IM, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2004 Apr;57(4):393-401. doi: 10.1046/j.1365-2125.2003.02034.x. Br J Clin Pharmacol. 2004. PMID: 15025736 Free PMC article. Clinical Trial.
Pharmacokinetics of oral fumarates in healthy subjects.
Litjens NH, Burggraaf J, van Strijen E, van Gulpen C, Mattie H, Schoemaker RC, van Dissel JT, Thio HB, Nibbering PH. Litjens NH, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2004 Oct;58(4):429-32. doi: 10.1111/j.1365-2125.2004.02145.x. Br J Clin Pharmacol. 2004. PMID: 15373936 Free PMC article. Clinical Trial.
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function.
Moerland M, Kales AJ, Schrier L, van Dongen MG, Bradnock D, Burggraaf J. Moerland M, et al. Among authors: burggraaf j. Int J Vasc Med. 2012;2012:904141. doi: 10.1155/2012/904141. Epub 2012 Feb 14. Int J Vasc Med. 2012. PMID: 22500237 Free PMC article.
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.
Dillingh MR, van den Blink B, Moerland M, van Dongen MG, Levi M, Kleinjan A, Wijsenbeek MS, Lupher ML Jr, Harper DM, Getsy JA, Hoogsteden HC, Burggraaf J. Dillingh MR, et al. Among authors: burggraaf j. Pulm Pharmacol Ther. 2013 Dec;26(6):672-6. doi: 10.1016/j.pupt.2013.01.008. Epub 2013 Feb 4. Pulm Pharmacol Ther. 2013. PMID: 23380438 Clinical Trial.
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP. Franciosi LG, et al. Among authors: burggraaf j. Lancet Respir Med. 2013 Nov;1(9):714-27. doi: 10.1016/S2213-2600(13)70187-5. Epub 2013 Oct 25. Lancet Respir Med. 2013. PMID: 24429275 Clinical Trial.
The use of biomarkers in human pharmacology (Phase I) studies.
Cohen AF, Burggraaf J, van Gerven JM, Moerland M, Groeneveld GJ. Cohen AF, et al. Among authors: burggraaf j. Annu Rev Pharmacol Toxicol. 2015;55:55-74. doi: 10.1146/annurev-pharmtox-011613-135918. Epub 2014 Oct 6. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292425 Review.
Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages.
Vlaming ML, van Duijn E, Dillingh MR, Brands R, Windhorst AD, Hendrikse NH, Bosgra S, Burggraaf J, de Koning MC, Fidder A, Mocking JA, Sandman H, de Ligt RA, Fabriek BO, Pasman WJ, Seinen W, Alves T, Carrondo M, Peixoto C, Peeters PA, Vaes WH. Vlaming ML, et al. Among authors: burggraaf j. Clin Pharmacol Ther. 2015 Aug;98(2):196-204. doi: 10.1002/cpt.131. Epub 2015 May 19. Clin Pharmacol Ther. 2015. PMID: 25869840 Clinical Trial.
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial.
van Poelgeest EP, Hodges MR, Moerland M, Tessier Y, Levin AA, Persson R, Lindholm MW, Dumong Erichsen K, Ørum H, Cohen AF, Burggraaf J. van Poelgeest EP, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2015 Dec;80(6):1350-61. doi: 10.1111/bcp.12738. Epub 2015 Oct 24. Br J Clin Pharmacol. 2015. PMID: 26261033 Free PMC article. Clinical Trial.
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.
van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J. van den Blink B, et al. Among authors: burggraaf j. Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869678 Free article. Clinical Trial.
Injection site reactions after subcutaneous oligonucleotide therapy.
van Meer L, Moerland M, Gallagher J, van Doorn MB, Prens EP, Cohen AF, Rissmann R, Burggraaf J. van Meer L, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2016 Aug;82(2):340-51. doi: 10.1111/bcp.12961. Epub 2016 May 31. Br J Clin Pharmacol. 2016. PMID: 27061947 Free PMC article. Review.
A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.
Kallend DG, Reijers JA, Bellibas SE, Bobillier A, Kempen H, Burggraaf J, Moerland M, Wijngaard PL. Kallend DG, et al. Among authors: burggraaf j. Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):23-9. doi: 10.1093/ehjcvp/pvv041. Epub 2015 Dec 11. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27418968 Free PMC article. Clinical Trial.
Renal Effects of Antisense-Mediated Inhibition of SGLT2.
van Meer L, Moerland M, van Dongen M, Goulouze B, de Kam M, Klaassen E, Cohen A, Burggraaf J. van Meer L, et al. Among authors: burggraaf j. J Pharmacol Exp Ther. 2016 Nov;359(2):280-289. doi: 10.1124/jpet.116.233809. Epub 2016 Sep 7. J Pharmacol Exp Ther. 2016. PMID: 27605629 Clinical Trial.
[Fosfomycin, an old antibiotic with new possibilities].
Dijkmans AC, Kuiper SG, Burggraaf J, Mouton JW, Wilms EB, Touw DJ, Stevens J, van Nieuwkoop C, Kamerling IMC. Dijkmans AC, et al. Among authors: burggraaf j. Ned Tijdschr Geneeskd. 2017;161:D973. Ned Tijdschr Geneeskd. 2017. PMID: 28612692 Dutch.
Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.
Heuberger JAAC, Rotmans JI, Gal P, Stuurman FE, van 't Westende J, Post TE, Daniels JMA, Moerland M, van Veldhoven PLJ, de Kam ML, Ram H, de Hon O, Posthuma JJ, Burggraaf J, Cohen AF. Heuberger JAAC, et al. Among authors: burggraaf j. Lancet Haematol. 2017 Aug;4(8):e374-e386. doi: 10.1016/S2352-3026(17)30105-9. Epub 2017 Jun 29. Lancet Haematol. 2017. PMID: 28669689 Clinical Trial.
Retinal microcirculation imaging in sickle cell disease patients.
Birkhoff W, de Vries J, Dent G, Verma A, Kerkhoffs JL, van Meurs AHF, de Kam M, Moerland M, Burggraaf J. Birkhoff W, et al. Among authors: burggraaf j. Microvasc Res. 2018 Mar;116:1-5. doi: 10.1016/j.mvr.2017.09.001. Epub 2017 Sep 22. Microvasc Res. 2018. PMID: 28943261
Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
Ducore J, Lawrence JB, Simpson M, Boggio L, Bellon A, Burggraaf J, Stevens J, Moerland M, Frieling J, Reijers J, Wang M. Ducore J, et al. Among authors: burggraaf j. Haemophilia. 2017 Nov;23(6):844-851. doi: 10.1111/hae.13357. Epub 2017 Oct 5. Haemophilia. 2017. PMID: 28984010 Clinical Trial.
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA. van der Kolk T, et al. Among authors: burggraaf j. Clin Transl Sci. 2018 Nov;11(6):607-615. doi: 10.1111/cts.12563. Epub 2018 Jul 3. Clin Transl Sci. 2018. PMID: 29768709 Free PMC article. Clinical Trial.
Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Males.
Kruithof AC, Kumar R, Stevens J, de Kam ML, Gautam A, Alikunju S, Padhi BK, Kulkarni S, Raghuvanshi RS, Gandhi R, Burggraaf J, Kamerling IMC. Kruithof AC, et al. Among authors: burggraaf j. Clin Pharmacol Drug Dev. 2019 Nov;8(8):1042-1052. doi: 10.1002/cpdd.707. Epub 2019 Jun 10. Clin Pharmacol Drug Dev. 2019. PMID: 31183985 Clinical Trial.
A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery.
de Valk KS, Handgraaf HJ, Deken MM, Sibinga Mulder BG, Valentijn AR, Terwisscha van Scheltinga AG, Kuil J, van Esdonk MJ, Vuijk J, Bevers RF, Peeters KC, Holman FA, Frangioni JV, Burggraaf J, Vahrmeijer AL. de Valk KS, et al. Among authors: burggraaf j. Nat Commun. 2019 Jul 16;10(1):3118. doi: 10.1038/s41467-019-11014-1. Nat Commun. 2019. PMID: 31311922 Free PMC article. Clinical Trial.
No effect of topical digoxin and furosemide gel for patients with external anogenital warts.
Rijsbergen M, Rijneveld R, Todd M, Pagan L, Feiss G, de Koning MNC, van Alewijk DCJG, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE. Rijsbergen M, et al. Among authors: burggraaf j. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e45-e46. doi: 10.1111/jdv.15894. Epub 2019 Sep 11. J Eur Acad Dermatol Venereol. 2020. PMID: 31430405 No abstract available.
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Niemeyer-van der Kolk T, Assil S, Buters TP, Rijsbergen M, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, van Doorn MBA, Rissmann R, Moerland M. Niemeyer-van der Kolk T, et al. Among authors: burggraaf j. Clin Transl Sci. 2020 May;13(3):573-579. doi: 10.1111/cts.12741. Epub 2020 Feb 13. Clin Transl Sci. 2020. PMID: 32043302 Free PMC article. Clinical Trial.
The Optimal Imaging Window for Dysplastic Colorectal Polyp Detection Using c-Met-Targeted Fluorescence Molecular Endoscopy.
de Jongh SJ, Vrouwe JPM, Voskuil FJ, Schmidt I, Westerhof J, Koornstra JJ, de Kam ML, Karrenbeld A, Hardwick JCH, Robinson DJ, Burggraaf J, Kamerling IMC, Nagengast WB. de Jongh SJ, et al. Among authors: burggraaf j. J Nucl Med. 2020 Oct;61(10):1435-1441. doi: 10.2967/jnumed.119.238790. Epub 2020 Mar 20. J Nucl Med. 2020. PMID: 32198312 Free article.
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma.
de Valk KS, Deken MM, Handgraaf HJM, Bhairosingh SS, Bijlstra OD, van Esdonk MJ, Terwisscha van Scheltinga AGT, Valentijn ARPM, March TL, Vuijk J, Peeters KCMJ, Holman FA, Hilling DE, Mieog JSD, Frangioni JV, Burggraaf J, Vahrmeijer AL. de Valk KS, et al. Among authors: burggraaf j. Clin Cancer Res. 2020 Aug 1;26(15):3990-3998. doi: 10.1158/1078-0432.CCR-19-4156. Epub 2020 Apr 28. Clin Cancer Res. 2020. PMID: 32345649 Clinical Trial.
Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.
Heuberger JAAC, Posthuma JJ, Ziagkos D, Rotmans JI, Daniels JMA, Gal P, Stuurman FE, Spronk HMH, Ten Cate H, Burggraaf J, Moerland M, Cohen AF. Heuberger JAAC, et al. Among authors: burggraaf j. Eur J Appl Physiol. 2020 Aug;120(8):1893-1904. doi: 10.1007/s00421-020-04419-0. Epub 2020 Jun 14. Eur J Appl Physiol. 2020. PMID: 32537688 Free PMC article. Clinical Trial.
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Verdijk P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, de Haan CAM, Roestenberg M, Burggraaf J, Kamerling IMC. Verdijk P, et al. Among authors: burggraaf j. Vaccine. 2020 Sep 3;38(39):6088-6095. doi: 10.1016/j.vaccine.2020.07.029. Epub 2020 Jul 25. Vaccine. 2020. PMID: 32718816 Free article. Clinical Trial.
Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
Niemeyer-van der Kolk T, Buters TP, Krouwels L, Boltjes J, de Kam ML, van der Wall H, van Alewijk DCJG, van den Munckhof EHA, Becker MJ, Feiss G, Florencia EF, Prens EP, Moerland M, Burggraaf J, Rissmann R, van Doorn MBA. Niemeyer-van der Kolk T, et al. Among authors: burggraaf j. J Am Acad Dermatol. 2022 Apr;86(4):854-862. doi: 10.1016/j.jaad.2020.08.132. Epub 2020 Oct 1. J Am Acad Dermatol. 2022. PMID: 33010325 Clinical Trial.
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Saghari M, Gal P, Ziagkos D, Burggraaf J, Powell JF, Brennan N, Rissmann R, van Doorn MBA, Moerland M. Saghari M, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2021 Apr;87(4):1953-1962. doi: 10.1111/bcp.14588. Epub 2020 Oct 28. Br J Clin Pharmacol. 2021. PMID: 33025648 Free PMC article. Clinical Trial.
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial.
Jacobse J, Ten Voorde W, Tandon A, Romeijn SG, Grievink HW, van der Maaden K, van Esdonk MJ, Moes DJAR, Loeff F, Bloem K, de Vries A, Rispens T, Wolbink G, de Kam M, Ziagkos D, Moerland M, Jiskoot W, Bouwstra J, Burggraaf J, Schrier L, Rissmann R, Ten Cate R. Jacobse J, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2021 Aug;87(8):3162-3176. doi: 10.1111/bcp.14729. Epub 2021 Feb 2. Br J Clin Pharmacol. 2021. PMID: 33403697 Free PMC article. Clinical Trial.
Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers.
Buters TP, Hameeteman PW, Jansen IME, van Hindevoort FC, Ten Voorde W, Florencia E, Osse M, de Kam ML, Grievink HW, Schoonakker M, Patel AA, Yona S, Gilroy DW, Lubberts E, Damman J, Feiss G, Rissmann R, Jansen MAA, Burggraaf J, Moerland M. Buters TP, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2022 Feb;88(2):680-690. doi: 10.1111/bcp.14999. Epub 2021 Aug 24. Br J Clin Pharmacol. 2022. PMID: 34293819 Free PMC article.
An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer.
Vrouwe JPM, Kamerling IMC, van Esdonk MJ, Metselaar JM, Stuurman FE, van der Pluijm G, Burggraaf J, Osanto S. Vrouwe JPM, et al. Among authors: burggraaf j. Pharmacol Res Perspect. 2021 Oct;9(5):e00845. doi: 10.1002/prp2.845. Pharmacol Res Perspect. 2021. PMID: 34414692 Free PMC article.
Administration of an adeno-associated viral vector expressing interferon-β in patients with inflammatory hand arthritis, results of a phase I/II study.
Vrouwe JPM, Meulenberg JJM, Klarenbeek NB, Navas-Cañete A, Reijnierse M, Ruiterkamp G, Bevaart L, Lamers RJ, Kloppenburg M, Nelissen RGHH, Huizinga TWJ, Burggraaf J, Kamerling IMC. Vrouwe JPM, et al. Among authors: burggraaf j. Osteoarthritis Cartilage. 2022 Jan;30(1):52-60. doi: 10.1016/j.joca.2021.09.013. Epub 2021 Oct 6. Osteoarthritis Cartilage. 2022. PMID: 34626797 Free article. Clinical Trial.
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers.
Buters TP, Hameeteman PW, Jansen IME, van Hindevoort FC, Ten Voorde W, Grievink HW, Schoonakker M, de Kam ML, Gilroy DW, Feiss G, Rissmann R, Jansen MAA, Burggraaf J, Moerland M. Buters TP, et al. Among authors: burggraaf j. Clin Pharmacol Ther. 2022 Apr;111(4):964-971. doi: 10.1002/cpt.2516. Epub 2022 Jan 6. Clin Pharmacol Ther. 2022. PMID: 34935141 Free PMC article.
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R. Saghari M, et al. Among authors: burggraaf j. Clin Pharmacol Ther. 2022 May;111(5):1121-1132. doi: 10.1002/cpt.2539. Epub 2022 Mar 1. Clin Pharmacol Ther. 2022. PMID: 35092305 Free PMC article. Clinical Trial.
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial.
Wind SS, Jansen MAA, Rijsbergen M, van Esdonk MJ, Ziagkos D, Cheng WC, Niemeyer-van der Kolk T, Korsten J, Gruszka A, Schmitz-Rohmer D, Bonnel D, Legouffe R, Barré F, Bekkenk MW, de Haas ERM, Quint KD, Rolli M, Streefkerk HJ, Burggraaf J, Vermeer MH, Rissmann R. Wind SS, et al. Among authors: burggraaf j. Cancers (Basel). 2022 Mar 15;14(6):1510. doi: 10.3390/cancers14061510. Cancers (Basel). 2022. PMID: 35326659 Free PMC article.
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Prins MLM, van der Plas JL, Vissers MFJM, Berends CL, Tresch G, Soergel M, Fernández E, van den Berge N, Duijsings D, Zitt C, Stavropoulou V, Zimmermann M, Drake RF, Burggraaf J, Groeneveld GH, Kamerling IMC. Prins MLM, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2023 Mar;89(3):1105-1114. doi: 10.1111/bcp.15560. Epub 2022 Oct 24. Br J Clin Pharmacol. 2023. PMID: 36214216 Free PMC article. Clinical Trial.
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.
Wind SS, Jansen MAA, Rijsbergen M, van Esdonk MJ, Ziagkos D, Cheng WC, Niemeyer-van der Kolk T, Korsten J, Gruszka A, Schmitz-Rohmer D, Bonnel D, Legouffe R, Barré F, Bekkenk MW, de Haas ERM, Quint KD, Schnidar H, Rolli M, Streefkerk HJ, Burggraaf J, Vermeer MH, Rissmann R. Wind SS, et al. Among authors: burggraaf j. Cancers (Basel). 2023 Feb 27;15(5):1485. doi: 10.3390/cancers15051485. Cancers (Basel). 2023. PMID: 36900424 Free PMC article.
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers.
Ten Voorde W, Saghari M, Boltjes J, de Kam ML, Zhuparris A, Feiss G, Buters TP, Prens EP, Damman J, Niemeyer-van der Kolk T, Moerland M, Burggraaf J, van Doorn MBA, Rissmann R. Ten Voorde W, et al. Among authors: burggraaf j. Exp Dermatol. 2023 Jul;32(7):1028-1041. doi: 10.1111/exd.14808. Epub 2023 Apr 13. Exp Dermatol. 2023. PMID: 37051698
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Rousel J, Saghari M, Pagan L, Nădăban A, Gambrah T, Theelen B, de Kam ML, Haakman J, van der Wall HEC, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, Bouwstra JA, Rissmann R, van Doorn MBA. Rousel J, et al. Among authors: burggraaf j. Int J Mol Sci. 2023 Sep 20;24(18):14315. doi: 10.3390/ijms241814315. Int J Mol Sci. 2023. PMID: 37762625 Free PMC article. Clinical Trial.
The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions.
Pagan L, Huisman BW, van der Wurff M, Naafs RGC, Schuren FHJ, Sanders IMJG, Smits WK, Zwittink RD, Burggraaf J, Rissmann R, Piek JMJ, Henderickx JGE, van Poelgeest MIE. Pagan L, et al. Among authors: burggraaf j. Front Microbiol. 2023 Nov 29;14:1264768. doi: 10.3389/fmicb.2023.1264768. eCollection 2023. Front Microbiol. 2023. PMID: 38094635 Free PMC article.
295 results